Clinical Trial Update: Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics [Phase 2]

View source ↗

Summary

The document reports completion of a Phase 2 multiple ascending dose study of TRN-157 in stable mild and moderate asthma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TRN-157

Snippet

Sponsor: Theron Pharmaceuticals, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED